Mark Alan Goldberg's Net Worth
$8.09 Million
Who is Mark Alan Goldberg?
Mark Alan Goldberg has an estimated net worth of $8.09 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., Blueprint Medicines Corp, IDERA PHARMACEUTICALS, INC., GLYCOMIMETICS INC, aTYR PHARMA INC, Audentes Therapeutics, Inc., and SYNAGEVA BIOPHARMA CORP.
SEC CIK
Mark Alan Goldberg's CIK is 0001532475
Past Insider Trading and Trends
2020 was Mark Alan Goldberg's most active year for acquiring shares with 16 total transactions. Mark Alan Goldberg's most active month to acquire stocks was the month of May. 2013 was Mark Alan Goldberg's most active year for disposing of shares, totalling 22 transactions. Mark Alan Goldberg's most active month to dispose stocks was the month of January. 2022 saw Mark Alan Goldberg paying a total of $448,180.00 for 136,278 shares, this is the most they've acquired in one year. In 2014 Mark Alan Goldberg cashed out on 71,932 shares for a total of $2,662,280.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ImmunoGen, Inc. (IMGN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -60.72K |
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +0.95% | 569 |
$29.65 | $16,870.85 | 60.72K |
Dec 29
| |||
Form 4
|
—
|
0
|
$14.89 | -$3,800.00 | 60.15K |
Scheduled
|
Oct 30
| ||
Form 4
| +1.80% | 1.06K |
$15.87 | $16,869.81 | 60.15K |
Sep 29
| |||
Form 4
| +1.54% | 894 |
$18.87 | $16,869.78 | 59.09K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +8.17% | 4.39K |
$3.84 | $16,872.96 | 58.19K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +126.05% | 30K |
$5.76 | $172,800.00 | 53.8K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +526.32% | 20K |
$1.80 | $36,000.00 | 23.8K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
| +375.00% | 3K |
$11.27 | $33,804.00 | 3.8K |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.00% | 2.24K |
—
|
—
| 18.25K |
Jun 12
| |||
Form 4
| +19.39% | 2.6K |
—
|
—
| 16.01K |
Jun 21
| |||
Form 4
| +24.05% | 2.6K |
—
|
—
| 13.41K |
Jun 21
| |||
Form 4
| +86.03% | 5K |
$59.98 | $299,900.00 | 10.81K |
Mar 3
| |||
Form 4
| +63.17% | 2.25K |
—
|
—
| 5.81K |
Jun 2
| |||
Form 4
|
—
|
0
|
$76.58 | -$528,316.75 | 3.56K |
Scheduled
|
Dec 24
| ||
Form 4
|
—
|
0
|
$74.08 | -$500,949.90 | 3.56K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
$71.58 | -$473,766.75 | 3.56K |
Scheduled
|
Dec 11
| ||
Form 4
|
—
|
0
|
$69.08 | -$446,409.90 | 3.56K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$62.27 | -$466,238.85 | 3.56K |
Scheduled
|
Oct 19
| ||
Form 4
|
—
|
0
|
$59.77 | -$438,883.38 | 3.56K |
Scheduled
|
Oct 7
| ||
Form 4
| +171.49% | 2.25K |
—
|
—
| 3.56K |
Jun 24
| |||
Form 4
|
∞
| 1.31K |
—
|
—
| 1.31K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDERA PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +22.64% | 4.58K |
$3.00 | $13,752.00 | 24.83K |
Mar 29
| |||
Form 4
| +40.42% | 5.83K |
$2.36 | $13,751.72 | 20.24K |
Dec 29
| |||
Form 4
| +174.61% | 9.17K |
$1.50 | $13,750.50 | 14.42K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 5.25K |
—
|
—
| 5.25K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +945.18% | 10.4K |
$4.77 | $49,630.08 | 11.5K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
aTYR PHARMA INC (LIFE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||